Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuyang Li

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The EMBO Journal|August 10, 2014
DNA end recognition by the Mre11 nuclease dimer: insights into resection and repair of damaged DNASihyun Sung, Fuyang Li, Young Bong Park, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 23, 2008
NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cellsLifeng Wang, Na Liu, Libo Yao, et al.
Biochemical and Biophysical Research Communications|November 18, 2006
The physical and functional interaction of NDRG2 with MSP58 in cellsJing Zhang, Junye Liu, Xia Li, et al.
The Journal of Biological Chemistry|October 20, 2006
The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoterJian Zhang, Fuyang Li, Xinping Liu, et al.
Nature Communications|May 26, 2018
Distinct roles of XPF-ERCC1 and Rad1-Rad10-Saw1 in replication-coupled and uncoupled inter-strand crosslink repairJa-Hwan Seol, Cory Holland, Xiaolei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2022
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor ModelsFuyang Li, Kathryn M Bondra, Samson Ghilu, et al.
International Journal of Cancer|July 8, 2003
N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferationYanchun Deng, Libo Yao, Ling Chau, et al.
Molecular Cancer Therapeutics|January 25, 2023
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood SarcomaTerry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The EMBO Journal|August 10, 2014
DNA end recognition by the Mre11 nuclease dimer: insights into resection and repair of damaged DNASihyun Sung, Fuyang Li, Young Bong Park, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 23, 2008
NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cellsLifeng Wang, Na Liu, Libo Yao, et al.
Biochemical and Biophysical Research Communications|November 18, 2006
The physical and functional interaction of NDRG2 with MSP58 in cellsJing Zhang, Junye Liu, Xia Li, et al.
The Journal of Biological Chemistry|October 20, 2006
The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoterJian Zhang, Fuyang Li, Xinping Liu, et al.
Nature Communications|May 26, 2018
Distinct roles of XPF-ERCC1 and Rad1-Rad10-Saw1 in replication-coupled and uncoupled inter-strand crosslink repairJa-Hwan Seol, Cory Holland, Xiaolei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2022
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor ModelsFuyang Li, Kathryn M Bondra, Samson Ghilu, et al.
International Journal of Cancer|July 8, 2003
N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferationYanchun Deng, Libo Yao, Ling Chau, et al.
Molecular Cancer Therapeutics|January 25, 2023
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood SarcomaTerry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, et al.
Pageof 4